Evidence map›Paper›PMID 21893120›Full record

ArticleGastroenterology2011

Trypsin reduces pancreatic ductal bicarbonate secretion by inhibiting CFTR Cl⁻ channels and luminal anion exchangers.

Petra Pallagi, Viktória Venglovecz, Zoltán Rakonczay, Katalin Borka, Anna Korompay, Béla Ozsvári, Linda Judák, Miklós Sahin-Tóth, Andrea Geisz, Andrea Schnúr and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. CFTR IVS8 Poly-T Variation Affects Severity of Acute Pancreatitis in Women.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2019
    Trial
  3. Trial
  4. Article
  5. Pathologically relevant trypsinogen activation in pancreatitis.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The role of CaCell calcium · 2023
    Review
  14. Review
  15. PAR2: The Cornerstone of Pancreatic Diseases.Physiological research · 2022
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Petra PallagiFirst Department of Medicine, University of Szeged, Szeged, Hungary.
Viktória Venglovecz
Zoltán Rakonczay
Katalin Borka
Anna Korompay
Béla Ozsvári
Linda Judák
Miklós Sahin-Tóth
Andrea Geisz
Andrea Schnúr
József Maléth
Tamás Takács
Mike A Gray
Barry E Argent
Julia Mayerle
Markus M Lerch
Tibor Wittmann
Péter Hegyi
University of Szeged · HUNewcastle University · GBSemmelweis University · HUUniversitätsmedizin Greifswald · DEBoston University · USHealth First · US

Funding

Chymotrypsin in pancreatitisR01DK082412 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAHIN-TOTH, MIKLOS · 2009 to 2024
$5.8M
Molecular Pathomechanism of Hereditary PancreatitisR01DK058088 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SAHIN-TOTH, MIKLOS · 2001 to 2019
$5.3M
NIDDK NIH HHS DK058088NIDDK NIH HHS R01 DK058088NIDDK NIH HHS R01 DK082412
6 · The paper itself

Abstract

BACKGROUND &

aimsThe effects of trypsin on pancreatic ductal epithelial cells (PDECs) vary among species and depend on the localization of proteinase-activated receptor 2 (PAR-2). We compared PAR-2 localization in human and guinea-pig PDECs, and used isolated guinea pig ducts to study the effects of trypsin and a PAR-2 agonist on bicarbonate secretion.

methodsPAR-2 localization was analyzed by immunohistochemistry in guinea pig and human pancreatic tissue samples (from 15 patients with chronic pancreatitis and 15 without pancreatic disease). Functionally, guinea pig PDECs were studied by microperfusion of isolated ducts, measurements of intracellular pH and intracellular Ca(2+) concentration, and patch clamp analysis. The effect of pH on trypsinogen autoactivation was assessed using recombinant human cationic trypsinogen.

resultsPAR-2 localized to the apical membrane of human and guinea pig PDECs. Trypsin increased intracellular Ca(2+) concentration and intracellular pH and inhibited secretion of bicarbonate by the luminal anion exchanger and the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel. Autoactivation of human cationic trypsinogen accelerated when the pH was reduced from 8.5 to 6.0. PAR-2 expression was strongly down-regulated, at transcriptional and protein levels, in the ducts of patients with chronic pancreatitis, consistent with increased activity of intraductal trypsin. Importantly, in PAR-2 knockout mice, the effects of trypsin were markedly reduced.

conclusionsTrypsin reduces pancreatic ductal bicarbonate secretion via PAR-2-dependent inhibition of the apical anion exchanger and the CFTR Cl(-) channel. This could contribute to the development of chronic pancreatitis by decreasing luminal pH and promoting premature activation of trypsinogen in the pancreatic ducts.

Indexed as

AnimalsAnion Exchange ResinsBicarbonatesCystic Fibrosis Transmembrane Conductance RegulatorEnzyme ActivationEpithelial CellsGuinea PigsHumansImmunohistochemistryMiceMice, Inbred C57BLMice, KnockoutPancreatic DuctsPancreatitis, ChronicReal-Time Polymerase Chain ReactionReceptor, PAR-2Anion Exchange ResinsBicarbonatesCystic Fibrosis Transmembrane Conductance RegulatorReceptor, PAR-2TrypsinTrypsinogen

Identifiers

PMID21893120
PMCPMC3273991
OpenAlexW2114825960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.